Author:
Hesson Ashley,Davis Melinda B.
Publisher
Springer International Publishing
Reference102 articles.
1. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, Fonarow GC. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc. 2014;3(3):e001056.
2. Sliwa K, Petrie MC, van der Meer P, Mebazaa A, Hilfiker-Kleiner D, Jackson AM, Bauersachs J. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J. 2020;41(39):3787–97.
3. Main EK, McCain CL, Morton CH, Holtby S, Lawton ES. Pregnancy related mortality in California: causes, characteristics, and improvement opportunities. Obstet Gynecol. 2015;125:938–47. https://doi.org/10.1097/AOG.0000000000000746.
4. https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Freproductivehealth%2Fmaternalinfanthealth%2Fpregnancy-mortality-surveillance-system.htm#causes.
5. Ersbøll AS, Johansen M, Damm P, Rasmussen S, Vejlstrup NG, Gustafsson F. Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail. 2017;19(12):1712–20.